SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.06500.0%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dirkdiggler who wrote (12080)6/13/2013 11:05:03 AM
From: jm2i1231 Recommendation

Recommended By
Jack Russell

  Read Replies (2) of 13111
 
1.you clearly have no knowledge or experience of how things work between phase2 and phase3. Yes things take forever. and that's the nature of the beast. Find me one investor, ONE, who says his/her biotech FDA-passed trials super fast, data released fast etc..etc..especially between phase2 and phase3 (and furthermore when an SPA is on the table, dozens of millions$ savings potential, etc..etc..)

2.If you're not happy to wait more, sell your shares. Investing in biotech is precisely that: Waiting.

3.they are not talking about selling the company to different bits they want to LICENSE the drug in some markets. Whats the problem with that? Wouldn't you do the same if you knew you could have a good shot at it, putting revenues on the spread sheet (better than debt) and thus hugely increasing the value of the business. Wouldn't you do that?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News